Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Combined Synopsis/Solicitation opportunity from Department Of Health And Human Services was posted on July 31, 2023. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Synthesis of repsox analogs and intermediates from multiple projects

Awarded
75N95023Q00548Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

Solicitation 75N95023Q00548 is a non-competitive request for quotation issued by the National Institute on Drug Abuse on behalf of the National Center for Advancing Translational Sciences. The acquisition seeks custom synthesis services for repsox analogs and intermediates from multiple medicinal chemistry campaigns. TargetMol Chemicals Inc. is identified as the sole source for this requirement due to their specialized expertise in small molecule synthesis, prior experience with these specific compounds, and established workflow with the agency, which ensures continuity and reduces the time and cost associated with developing new synthetic procedures. The contract is intended as a firm fixed-price purchase order with a period of performance of six months after receipt of order. The contractor is required to produce milligram to gram quantities of compounds, providing analytical purity data via LCMS and 1H NMR along with monthly progress reports. This acquisition is conducted under FAR Part 13 Simplified Acquisition Procedures and FAR Part 12 for Commercial Items, utilizing NAICS code 541380. All invoicing and payments must be processed through the Invoice Processing Platform in accordance with the Prompt Payment Act.

General Info

Contract Value

$99,000

NAICS

541380 - Testing Laboratories and Services

Place of Performance

MD, USA

Set-Aside

NONE

Award Issued Date

Documents

3

FAR 52.212-5 Contract Terms and Conditions (Jun 2023)

PDF, High priority: read this firstcontract-document
High

Invoice and Payment Provisions (IPP)

PDF, High priority: read this firstspecifications
High

SOW - Synthesis of reposox analogs and intermediates

PDF, High priority: read this firstsow
High

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseAwarded
Posted

Combined Synopsis

Awarded

Contract was awarded

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Nida
Contacts1 person available
OfficeBethesda, MD, 20892, USA
Office AddressBethesda, MD, 20892, USA

Full Description

Show more
NON-COMPETITIVE COMBINED SYNOPSIS / SOLICITATION Title: Synthesis of repsox analogs and intermediates from multiple projects (i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. (ii) The solicitation number is 75N95023Q00548 and the solicitation is issued as a request for quotation (RFQ). This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13'Simplified Acquisition Procedures; and FAR Part 12'Acquisition of Commercial Items, and is not expected to exceed the simplified acquisition threshold. THIS IS A NON-COMPETITIVE (NOTICE OF INTENT) COMBINED SYNOPSIS SOLICITATION TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). The National Institute on Drug Abuse (NIDA), Office of Acquisition (OA), on behalf the National Center for Advancing Translational Sciences (NCATS), intends to negotiate and award a purchase order without providing for full and open competition (including brand-name) to: TargetMol Chemicals Inc. Wellesley Hills, Massachusetts 02481 USA www.targetmol.com for custom synthesis services. This acquisition is conducted as non-competitive for a commercial item or service and is conducted pursuant to FAR 13.106-1(b)(1). The essential characteristics of the Testing of compounds in kinetic profiling assays that limit the availability to a sole source are that TargetMol has deep expertise in the synthesis of small molecules such as repsox and custom intermediates that are a part of this requirement. They have prior experience in synthesizing the same compounds and similar analogs; thus, they will use synthetic methods, analytical techniques and purification methods they have already developed. For a new vendor, considerable time and effort will be required to develop procedures that can provide the synthetic targets in this requisition; potentially jeopardizing the timeline. This prior familiarity of work will save the government time and cost associated with the service. In addition, TargetMol has worked successfully on prior contracts within NCATS that have very similar work to this requirement. Utilizing TargetMol will ensure continuity of the prior workflow established between the vendor and NCATS. (iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) Number 2023-04, with effective date June 02, 2023. (iv) The associated NAICS code is 541380 and the small business size standard is $19M. This requirement is a sole source acquisition to TargetMol Chemicals, Inc. with no set-aside restrictions. (v) This requirement is for the following services: NCATS ETB needs to produce analogs of repsox and intermediates from 2 other ongoing medicinal chemistry campaigns that will be derivatized to produce analogs. See Attachment 1-Statement of Work (vi) The Government anticipates award of a firm fixed-price purchase order for this acquisition, and the anticipated period of performance is 6 months after receipt of order (ARO). (vii) The additional instructions to offerors are as follows: The provision at FAR 52.252-1, Solicitation Provisions Incorporated by Reference (Feb 1998), applies to this acquisition. This solicitation incorporates one or more solicitation provisions by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. The offeror is cautioned that the listed provisions may include blocks that must be completed by the offeror and submitted with its quotation or offer. In lieu of submitting the full text of those provisions, the offeror may identify the provision by paragraph identifier and provide the appropriate information with its quotation or offer. Also, the full text of a solicitation provision may be accessed electronically at these addresses: https://www.acquisition.gov/browse/index/far https://www.hhs.gov/grants/contracts/contract-policies-regulations/hhsar/index.html (End of provision) The following provisions apply to this acquisition and are incorporated by reference: FAR 52.204-7, System for Award Management (Oct 2018) FAR 52.204-16, Commercial and Government Entity Code Reporting (Aug 2020) FAR 52.212-1, Instructions to Offerors-Commercial Products and Commercial Services (Mar 2023) FAR 52.212-3, Offeror Representations and Certifications-Commercial Products and Commercial Services (Dec 2022) HHSAR 352.239-73, Electronic and Information Technology Accessibility Notice (December 18, 2015) The clause at FAR 52.252-2, Clauses Incorporated by Reference (Feb 1998), applies to this acquisition. This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at these addresses: https://www.acquisition.gov/browse/index/far https://www.hhs.gov/grants/contracts/contract-policies-regulations/hhsar/index.html (End of clause) The following clauses apply to this acquisition and are incorporated by reference: FAR 52.204-13, System for Award Management Maintenance (Oct 2018) FAR 52.204-18, Commercial and Government Entity Code Maintenance (Aug 2020) FAR 52.212-4, Contract Terms and Conditions-Commercial Products and Commercial Services (Dec 2022). Addendum to this FAR clause applies to this acquisition and is attached. HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (December 18, 2015) HHSAR 352.239-74, Electronic and Information Technology Accessibility (December 18, 2015) The following provisions and clauses apply to this acquisition and are attached in full text. Offerors MUST complete the provisions at 52.204-24 and 52.204-26 and submit completed copies as separate documents with their proposal. FAR 52.204-24 Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment (Nov 2021) FAR 52.204-26 Covered Telecommunications Equipment or Services-Representation (Oct 2020) FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders-Commercial Products and Commercial Services (Dec 2022) NIH Invoice and Payment Provisions (viii) The Government plans to make one award resulting from this solicitation. The resulting award will be made to TargetMol Chemicals, Inc. as long as its quotation is technically acceptable and at a fair and reasonable price. If additional quotations are received, the award will be made to the vendor who represents the best value to the Government, price and other factors considered. (ix) The Offerors to include a completed copy of the provision at FAR clause 52.212-3, Offeror Representations and Certifications-Commercial Items (Dec 2022), with its offer. If the offeror has completed FAR clause 52.212-3 at www.sam.gov, then the offeror does not need to provide a completed copy with its offer. (x) The clause at FAR 52.212-4, Contract Terms and Conditions-Commercial Products and Commercial Services (Dec 2022), applies to this acquisition. Addendum to this FAR clause applies to this acquisition and is attached. (xi) There are no additional contract requirement(s) or terms and conditions applicable to this acquisition. (xii) The Defense Priorities and Allocations System (DPAS) are not applicable to this requirement. (xii) Responses to this solicitation must include clear and convincing evidence of the offeror's capability of fulfilling the requirement as it relates to the technical evaluation criteria. The price proposal must include the labor categories, an estimate of the number of hours required for each labor category, fully loaded fixed hourly rate or each labor category, breakdown and rationale for other direct costs or materials, and the total amount. The Unique Entity ID from SAM.gov, the Taxpayer Identification Number (TIN), and the certification of business size must be included in the response. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov. All quotations must be received by 1:00 p.m., Eastern Standard Time, on August 3, 2023, and reference Solicitation Number 75N95023Q00548. Responses must be submitted electronically to Samson Shifaraw, Contracts Specialist, at contact@example.gov. Fax responses will not be accepted.

More opportunities from Department Of Health And Human Services → National Institutes Of Health Nida

Same awarding agency

NAICS: 541990
New
Federal
SMART IRB Governance, Administration, and Operations Support (GAOS)
Solicitation # 75N98026Q00287
The National Center for Translational Sciences (NCATS), under the National Institutes of Health, is seeking a partner to provide Governance, Administration, and Operations Support (GAOS) for the SMART IRB portfolio of services. The selected contractor will facilitate user administration, process and workflow improvements, content development and moderation, and requirements gathering. This support extends across three primary systems: the SMARTIRB.org website for education and content distribution, the Joinder system for institutional authorization agreements, and the Online Reliance System (ORS) for documenting study-specific IRB reliance arrangements. This is a full and open competition for commercial services conducted under FAR Part 12 and FAR Subpart 13.5, with a NAICS code of 541990. The anticipated period of performance consists of a 12-month base period starting January 1, 2027, followed by three 12-month option periods and one final 6-month option period ending June 30, 2031. Performance will take place at the contractor's facility. Award decisions will be based on the most advantageous offer, evaluated against management approach and technical capabilities, personnel qualifications, and organizational experience. Key deliverables include monthly status reports, quarterly metrics and analysis, and a final closeout report. All invoices must be processed electronically through the Department of Treasury Invoice Processing Platform.
All Other Professional, Scientific, and Technical Services

POSTED

1 day ago

DEADLINE

in 15 days
View Details

Earlier notices in this NAICS code

Posted before this notice, open and closed

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS